Best Voip Service Providers Chart
		$9.95 - $16.58
		$19.99 - $39.99
		$9.95 - $15.95

LaVoie Strategic Communications Group, Inc. Adds Three New Life Science Clients to Growing Roster

LaVoie Strategic Communications Group, Inc. (LaVoie Group), a life sciences focused public and investor relations firm, announced today that it has been selected by publicly-traded Javelin Pharmaceuticals of Cambridge, MA, and IBEX Technologies, Inc. of Montreal, Canada, both as agency of record. LaVoie Group also announced that it has been selected to represent privately-held, VisEn Medical, Inc., of Woburn, MA.

To facilitate the growing client demand, LaVoie Group will be expanding its presence with new offices in Salem, Massachusetts and Greenwich, Connecticut.

"LaVoie Group is focused on providing strategic counsel and superior execution to our growing roster of US and international clients. We have aligned ourselves with some of the industry's best development-stage companies who are positioned to become tomorrow's leaders. We look forward to growing with them," said Donna L. LaVoie, President and CEO, LaVoie Group.

About LaVoie Group

LaVoie Group provides senior level strategic counsel and tactical implementation of public, investor and corporate communications programs designed to properly position, create visibility and drive value for each client. Our clients range from start-ups to industry leaders.

About Javelin Pharmaceuticals, Inc.

Javelin (OTC Bulletin Board: JVPH.OB) is a specialty pharmaceutical company, applying innovative, proprietary technologies to develop new drugs and improved formulations of existing drugs to target unmet and underserved medical needs in the pain management market. For additional information, visit http://www.javelinpharmaceuticals.com.

About IBEX Technologies

IBEX (TSX: IBT) is focused on the development of therapeutics and diagnostics for the management of cancer and arthritis. The Company's cancer program is based on a family of genes known as kallikreins. Its arthritis program is based on a series of biomarkers of collagen degradation and synthesis.

IBEX markets a number of products, including its proprietary enzymes (heparinases and chondroitinases), as well as a series of arthritis and kallikrein-based assays. For more information visit, http://www.ibex.ca.

About VisEn Medical

VisEn Medical is developing leading edge optical molecular imaging technology platforms for use in animal research and ultimately into clinic research. VisEn's products focus on molecular imaging of central disease states, including oncology, bone growth, cardiovascular disease and inflammation. For further information visit, http://www.visenmedical.com.

Author:  

Email:    

Topic:    

Content:

Related Telecom Articles

• Vistula Communications Services, Inc. Announces $16.5 Million Private Placement
  23 May 2006



• Silk telecom Building New Optical Network With Nortel
  23 May 2006



• This Almost-Magical Investing Software From Aptus Communications Automatically Selects Undervalued Stocks Before Others Even Know They Exist
  21 May 2006



• Talking Communications with Farrell Kramer Podcast Releases Episode 4 -- Don't Do This: The Biggest Mistakes You Can Make with Reporters
  21 May 2006



• 21 Communications Opens New Wireless Channel for Warner China Film HG Corporation
  19 May 2006



• TheTelecomDirectory.com Launches New Site for the Worldwide Telecom Industry
  19 May 2006



• Notice to All Current and Former Kiewit Employees with Concentrated Positions In Level 3 Communications and WorldCom from the Securities Arbitration L
  18 May 2006



• RealMarCom Provides Mortgage Marketing Professionals Free Resources for Effective Mortgage Marketing Communications in Latest Issue of "Mortgage
  18 May 2006



• First Point Inc. Named Strategic Sales Partner for Telco Television Corporation's IPTV Solutions
  18 May 2006



• Esnatech Rolls Out beta for its Real-Time Communications Platform
  18 May 2006